What happened at the GU Cancers Symposium yesterday?

So at the Genitourinary Cancers Symposium yesterday in San Francisco we were treated to: … READ MORE …

PCF’s State of the Science Report from 2017

The Prostate Cancer Foundation (PCF) has just issued its annual “State of the Science Report” based on presentations given at the 24th Annual PCF Scientific Retreat (held last year in October in Washington, DC). … READ MORE …

Reports from the ESOU18 meeting in Amsterdam

Once again, in the interests of not wasting everyone’s time (your sitemaster’s included), we recommend a look at the recent reports on some 20+ presentations given at the recent meeting of the European Society for Oncologic Urology (ESOU). … READ MORE …

Might we see generic abiraterone acetate this year?

On Wednesday the U.S. Patent Trial and Appeal Board invalidated the last remaining patent on abiraterone acetate (Zytiga), making it possible that generic forms of abiraterone acetate would be available in 2018 (at least in the US). … READ MORE …

What did the patient actually die of?

Two questions that come up regularly are whether: (a) men who are said to have died of prostate cancer actually did, and (b) men with prostate cancer who are said to have died of something else actually died of their prostate cancer. … READ MORE …

How “average Americans” think about cancer today

Earlier this year the American Society for Clinical Oncology (ASCO) worked with the Harris Poll to put in place ASCO’s first annual National Cancer Opinion Survey. We thought many of our readers might be interested in the findings. … READ MORE …

Enzalutamide treatment and risk for seizures

The “Warnings and Precautions” section of the product prescribing information for enzalutamide (Xtandi) includes the following statement: … READ MORE …